|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/70 | |
| A61K 31/485 | |||
| A61K 47/38 | |||
| A61P 25/36 |
| (11) | Patento numeris | 2552425 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11715120.9 |
| Europos patento paraiškos padavimo data | 2011-04-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-02-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-07-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/031135 |
| Data | 2011-04-04 |
| (87) | Numeris | WO 2011/123866 |
| Data | 2011-10-06 |
| (30) | Numeris | Data | Šalis |
| 320526 P | 2010-04-02 | US |
| (72) |
STINCHCOMB, Audra, Lynn, US
LI, Guohua, US
BANKS, Stan, Lee, US
HOWARD, Jeffery, Lynn, US
GOLINSKI, Miroslaw, Jerzy, US
|
| (73) |
Buzzz Pharmaceuticals Limited,
15 Main Street Raheny, Dublin 5,
IE
|
| (54) | ABUSE-DETERRENT TRANSDERMAL FORMULATIONS OF OPIATE AGONISTS AND AGONIST-ANTAGONISTS |
| ABUSE-DETERRENT TRANSDERMAL FORMULATIONS OF OPIATE AGONISTS AND AGONIST-ANTAGONISTS |